The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
Pediatric foot deformity is a term that includes a range of conditions that may affect the bones, tendons, and muscles of the foot. Among those most frequently treated at HSS are cavus foot, tarsal ...
The global medical tubing market is projected to grow from US$ 13.27 billion in 2023 to US$ 23.55 billion by 2031, at a CAGR of 7.4%. This growth is driven by the increasing demand for advanced ...